EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The paths toward immunotherapy of esophageal cancer: An overview of clinical trials

Azfar Jamal, Allolo D Aldreiwish, Saeed S Banawas, Yaser E Alqurashi, Mohammad Azhar Kamal, Fuzail Ahmad

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Azfar Jamal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science Al-Zulfi, Majmaah University, Al-Majmaah 11952, Saudi Arabia; Health and Basic Science Research Centre, Maj…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: AlMaarefa University, Majmaah University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the seventh-leading contributor to global cancer-related deaths, esophageal cancer (EC) is one of the most challenging types of cancer. Despite advancements in conventional therapies, including surgery, chemotherapy, and radiotherapy, the five-year survival rate remains low, underscoring the need for the development of more efficacious treatment approaches. Immunotherapy has emerged as a promising treatment approach, offering new hope for EC patients. This review provides an in-depth examination of the latest immunotherapeutic strategies for EC, focusing on immune checkpoint inhibitors, adoptive cell therapy, cancer vaccines, and oncolytic virotherapy. We critically analyze the current clinical data to highlight the progress and pitfalls of each immunotherapeutic approach for EC. Additionally, we explore the potential for combination therapies, which could overcome the resistance often seen with monotherapies. Finally, we discuss the limitations of current treatments and outline key areas for future research to improve patient outcomes and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsImmunotherapyImmune Checkpoint InhibitorsHumansCancer VaccinesOncolytic VirotherapyClinical Trials as TopicAnimalsCombined Modality Therapy

Stichwörter der Autor:innen

Adoptive cell therapyCancer vaccinesEsophageal cancerImmune checkpoint inhibitorsImmunotherapyOncolytic virotherapy

Substanzen

Cancer VaccinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Biology, College of Science Al-Zulfi, Majmaah University, Al-Majmaah 11952, Saudi Arabia; Health and Basic Science Research Centre, Majmaah University, Al-Majmaah 11952, Saudi Arabia. Electronic address: a…
  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah 11952, Saudi Arabia.
  • Health and Basic Science Research Centre, Majmaah University, Al-Majmaah 11952, Saudi Arabia; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah 11952, Saudi Arab…
  • Department of Biology, College of Science Al-Zulfi, Majmaah University, Al-Majmaah 11952, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
  • Respiratory Care Department, College of Applied Sciences, Almaarefa University, Diriya, Riyadh 13713, Saudi Arabia.

Förderung

  • AlMaarefa University
  • Majmaah University

Zitieren

APA

Jamal, A., Aldreiwish, A. D., Banawas, S. S., Alqurashi, Y. E., Kamal, M. A., & Ahmad, F. (2025). The paths toward immunotherapy of esophageal cancer: An overview of clinical trials. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114261

Vancouver

Jamal A, Aldreiwish AD, Banawas SS, Alqurashi YE, Kamal MA, Ahmad F. The paths toward immunotherapy of esophageal cancer: An overview of clinical trials. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114261

BibTeX
@article{Jamal2025,
  author = {Jamal, Azfar and Aldreiwish, Allolo D and Banawas, Saeed S and Alqurashi, Yaser E and Kamal, Mohammad Azhar and Ahmad, Fuzail},
  title = {The paths toward immunotherapy of esophageal cancer: An overview of clinical trials},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114261}
}
Kostenlos starten →